ロード中...
Analysis of cabazitaxel‐resistant mechanism in human castration‐resistant prostate cancer
Cabazitaxel (CBZ) is approved for docetaxel‐resistant castration‐resistant prostate cancer (CRPC). However, efficacy of CBZ for CRPC is limited and there are no effective treatments for CBZ‐resistant CRPC. In order to investigate the CBZ‐resistant mechanism, the establishment of a CBZ‐resistant cell...
保存先:
| 出版年: | Cancer Sci |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6125448/ https://ncbi.nlm.nih.gov/pubmed/29989268 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13729 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|